Disclosure Of Intangible Assets [Text Block]

Pharming Group N.V. - Filing #5829944

Concept As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
Disclosure of intangible assets [text block]
Disclosure of detailed information about intangible assets [text block]
Disclosure of detailed information about intangible assets [abstract]
Disclosure of detailed information about intangible assets [line items]
Reconciliation of changes in intangible assets other than goodwill [abstract]
Intangible assets other than goodwill
61,039,000 USD
71,267,000 USD
Research and development expense
83,147,000 USD
68,914,000 USD

Talk to a Data Expert

Have a question? We'll get back to you promptly.